Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday

Stock Markets Aug 10, 2022 09:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
 
IXIC
-1.51%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TGTB34
-0.22%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Gainers

  • AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
  • BBQ Holdings, Inc. (NASDAQ: BBQ) jumped 46.6% to close at $17.18 after the company announced MTY Food Group entered into a definitive merger agreement to acquire all of the outstanding shares of the company for $17.25 per share.
  • Verona Pharma plc (NASDAQ: VRNA) shares climbed 44.3% to close at $10.03 on Tuesday after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
  • FaZe Holdings Inc. (NASDAQ: FAZE) gained 42.4% to settle at $20.08 on continued volatility following the company's recent completion of its SPAC merger.
  • Cuentas Inc. (NASDAQ: CUEN) gained 35.2% to close at $0.8543.
  • Mersana Therapeutics, Inc. (NASDAQ: MRSN) shares climbed 33.3% to settle at $7.00. Mersana Therapeutics announced a global collaboration that provides GSK plc an exclusive option to co-develop and commercialize XMT-2056.
  • Avalo Therapeutics, Inc. (NASDAQ: AVTX) gained 32.1% to settle at $5.18. Avalo Therapeutics has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER).
  • Akanda Corp. (NASDAQ: AKAN) climbed 30.2% to close at $1.25. Akanda will supply Cansativa with premium indoor cannabis flower grown at its Sintra facility in Portugal.
  • Atara Biotherapeutics, Inc. (NASDAQ: ATRA) jumped 29.2% to close at $4.69 after reporting a profit for the second quarter.
  • ReTo Eco-Solutions, Inc. (NASDAQ: RETO) jumped 25.9% to close at $0.9212 after the company announced its subsidiary REIT Ecological Technology has won the bid for the Longxi County Comprehensive Land Management and Logistics Zone EOD Project.
  • DPCM Capital, Inc. (NYSE: QBTS) gained 24% to settle at $12.40. D-Wave Quantum is expected to release its financial results for the second quarter on Tuesday, August 16, 2022 after market close.
  • PubMatic, Inc. (NASDAQ: PUBM) climbed 23.8% to close at $21.98 after reporting strong quarterly results.
  • RenovoRx, Inc. (NASDAQ: RNXT) gained 23.6% to settle at $2.62.
  • Tuesday Morning Corporation (NASDAQ: TUEM) gained 22.2% to close at $0.44 after gaining around 68% on Monday.
  • Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) rose 21.5% to settle at $8.86.
  • Nielsen Holdings plc (NYSE: NLSN) surged 21.3% to close at $27.54. Nielsen postponed court and special meetings of shareholders to permit finalization of preliminary agreement between consortium and The WindAcre Partnership LLC.
  • Edgio, Inc. (NASDAQ: EGIO) gained 20.6% to settle at $3.39 after the company reported better-than-expected Q2 results.
  • RumbleON, Inc. (NASDAQ: RMBL) jumped 19.4% to close at $24.41 after the company reported better-than-expected Q2 results.
  • IDW Media Holdings, Inc. (NYSE: IDW) surged 18.3% to settle at $1.62.
  • Performance Shipping Inc. (NASDAQ: PSHG) rose 17.8% to settle at $0.41.
  • Ambac Financial Group, Inc. (NYSE: AMBC) gained 17.4% to close at $13.09 following upbeat Q2 results.
  • ShockWave Medical, Inc. (NASDAQ: SWAV) climbed 17.1% to settle at $259.61 after the company reported better-than-expected Q2 EPS and sales results and raised FY22 sales guidance above analyst estimates.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 16.4% to settle at $0.5333
  • Ontrak, Inc. (NASDAQ: OTRK) shares climbed 16.1% to close at $0.79. Ontrak recently reported closing of registered direct offering for aggregate gross proceeds of $4.0 million.
  • Tricida, Inc. (NASDAQ: TCDA) surged 15.5% to close at $12.47 following strong quarterly earnings.
  • Heron Therapeutics, Inc. (NASDAQ: HRTX) gained 15.1% to close at $4.11 after the company posted upbeat quarterly sales and raised FY22 net product sales guidance.
  • AlloVir, Inc. (NASDAQ: ALVR) jumped 14% to close at $8.00. The company recently released quarterly results.
  • American Equity Investment Life Holding Company (NYSE: AEL) jumped 13% to close at $40.95 after the company reported better-than-expected Q2 EPS and sales results.
  • Lemonade, Inc. (NYSE: LMND) shares rose 12.2% to close at $28.16 after the company reported better-than-expected Q2 results and issued sales guidance above estimates.
  • Qualys, Inc. (NASDAQ: QLYS) climbed 12% to close at $142.70 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 sales guidance above analyst estimates.
  • PowerSchool Holdings, Inc. (NYSE: PWSC) gained 9.3% to settle at $16.89 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 and FY22 sales guidance above analyst estimates.
  • Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) climbed 8.1% to close at $39.77. Stifel maintained Cerevel Therapeutics with a Buy and raised the price target from $50 to $54.
  • Nutex Health, Inc. (NASDAQ: NUTX) gained 8% to settle at $3.93.
  • Luminar Technologies, Inc. (NASDAQ: LAZR) rose 7.7% to close at $8.52 after the company reported better-than-expected Q2 sales results.
  • Viasat, Inc. (NASDAQ: VSAT) gained 7.3% to $37.30 after the company reported Q1 results.
  • Principal Financial Group, Inc. (NYSE: PFG) gained 7.1% to settle at $73.69 after the company reported better-than-expected Q2 adjusted EPS results. Additionally, Morgan Stanley (NYSE:MS) raised its price target from $65 to $68.
  • Enovix Corporation (NASDAQ: ENVX) rose 5.2% to close at $14.41 after declining around 5% on Monday. JP Morgan recently initiated coverage on Enovix with an Overweight rating and announced a price target of $20.
  • News Corporation (NASDAQ: NWSA) gained 5.2% to close at $18.27 after the company reported Q4 EPS results up year over year and better-than-expected sales results.

Losers

  • Magic Empire Global Limited (NASDAQ: MEGL) dipped 89.5% to close at $12.32 on volatility following the company's IPO on Friday.
  • CorMedix Inc. (NASDAQ: CRMD) fell 57.5% to close at $3.20 after the company announced it received a second Complete Response Letter from the FDA stating that the DefenCath NDA cannot be approved until certain deficiencies are resolved to the satisfaction of the FDA.
  • Quanterix Corporation (NASDAQ: QTRX) shares fell 54.8% to close at $7.46 after the company announced Q2 results and provided an update on clinical development programs.
  • Aytu BioPharma, Inc. (NASDAQ: AYTU) shares dipped 51.5% to close at $0.2814 after the company announced the launch of public offering.
  • AMTD Digital Inc. (NYSE: HKD) dropped 47.7% to close at $212.00 on possible profit taking after the stock surged over the last few trading days.
  • Medicenna Therapeutics Corp. (NASDAQ: MDNA) fell 46.6% to close at $0.95 after the company announced the launch of a marketed underwritten public offering of 13,333,334 units priced at $1.50 per unit.
  • Avaya Holdings Corp. (NASDAQ: AVYA) dipped 45.5% to close at $0.6101 after the company issued Q3 EPS and sales guidance below analyst estimates.
  • Vertex (NASDAQ:VRTX) Energy, Inc. (NASDAQ: VTNR) declined 44.2% to settle at $7.80 after the company reported worse-than-expected Q2 EPS.
  • SKYX Platforms Corp. (NASDAQ: SKYX) dropped 41.4% to close at $3.60. SKYX achieved historic U.S. standardization approval vote – a major milestone towards mandatory status for safety of consumers and professionals.
  • Endo International plc (NASDAQ: ENDP) declined 39.7% to settle at $0.4030 after the company reported a 20% year-over-year drop in Q2 revenues and said it remains in negotiations with creditors. The company expects negotiations to result in a pre-arranged filing under Chapter 11 of the U.S. Bankruptcy Code.
  • Senmiao Technology Limited (NASDAQ: AIHS) dipped 36.8% to close at $1.20 after the company reported ride-hailing platform operating metrics for July.
  • Vroom, Inc. (NASDAQ: VRM) dropped 35.4% to close at $1.59 after the company reported worse-than-expected Q2 sales.
  • DermTech, Inc. (NASDAQ: DMTK) declined 34.1% to close at $5.56 after the company reported worse-than-expected Q2 sales results.
  • Turtle Beach Corporation (NASDAQ: HEAR) shares fell 31.8% to close at $9.54 after reporting downbeat second quarter financial results and announced an update to a strategic review.
  • Novavax, Inc. (NASDAQ: NVAX) dipped 29.6% to close at $40.28 after the company reported second-quarter revenue decline of 37.6% year-over-year to $185.9 million. The company also lowered its sales forecast for the year.
  • Oportun Financial Corporation (NASDAQ: OPRT) fell 28.5% to close at $7.70 following Q2 results.
  • Intelligent Living Application Group Inc. (NASDAQ: ILAG) dropped 28.4% to close at $3.63.
  • Assure Holdings Corp. (NASDAQ: IONM) fell 28% to settle at $1.72.
  • eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares declined 27.4% to close at $0.6520 on Tuesday. eFFECTOR Therapeutics appointed Douglas Warner, M.D., as chief medical officer.
  • Eargo, Inc. (NASDAQ: EAR) dipped 27% to settle at $1.00 after the company posted a wider Q2 loss.
  • Quanergy Systems, Inc. (NYSE: QNGY) fell 26.6% to close at $0.3302.
  • Bonso Electronics International Inc. (NASDAQ: BNSO) fell 26.5% to close at $5.79 after gaining 65% on Monday.
  • SOS Limited (NYSE: SOS) fell 26.3% to close at $7.30.
  • Xilio Therapeutics, Inc. (NASDAQ: XLO) dropped 26.2% to close at $2.42 after the company provided an update of its preliminary Phase 1 dose-escalation data for XTX101. The company also reported Q2 financial results.
  • CarGurus, Inc. (NASDAQ: CARG) fell 25.5% to close at $19.16 after the company issued weak forecast for the third quarter.
  • Superior Group of Companies, Inc. (NASDAQ: SGC) declined 25.4% to end at $13.93 following downbeat quarterly earnings.
  • Root, Inc. (NASDAQ: ROOT) fell 24.8% to close at $1.03 after the company reported Q2 results and announced a 1-for-18 reverse stock split.
  • American Vanguard Corporation (NYSE: AVD) declined 24.3% to close at $18.29 after the company reported worse-than-expected Q2 sales results.
  • TaskUs, Inc. (NASDAQ: TASK) dropped 24.3% to close at $17.73 after the company issued FY22 sales guidance below estimates.
  • Workhorse Group Inc. (NASDAQ: WKHS) fell 24.2% to settle at $3.39 after the company reported Q2 earnings results and said it now expects to manufacture and sell between 150 to 250 vehicles and generate between $15 million to $25 million in revenue for calendar year 2022.
  • Minerva Neurosciences, Inc. (NASDAQ: NERV) dropped 23.9% to close at $3.60 after the company reported Q2 earnings results.
  • Artelo Biosciences, Inc. (NASDAQ: ARTL) dipped 23.6% to close at $0.2701 after the company reported Q3 EPS results were lower year over year. Also, the company announced a 15-for-1 reverse stock split.
  • Westport Fuel Systems Inc. (NASDAQ: WPRT) declined 22.6% to close at $1.20 after reporting a Q2 loss.
  • Palisade Bio, Inc. (NASDAQ: PALI) fell 22.1% to close at $0.4050.
  • Evofem Biosciences, Inc. (NASDAQ: EVFM) dropped 22% to close at $0.6240.
  • LivePerson, Inc. (NASDAQ: LPSN) fell 21.8% to close at $12.95 after the company reported worse-than-expected Q2 EPS and sales results. The company also lowered FY22 sales guidance below analyst estimates and issued Q3 sales guidance below estimates.
  • National CineMedia, Inc. (NASDAQ: NCMI) dropped 21.6% to close at $1.3950 following Q2 results.
  • Iveda Solutions, Inc. (NASDAQ: IVDA) fell 21.4% to close at $1.40. Iveda Solutions announced a $5 million private placement.
  • AMTD IDEA Group (NYSE: AMTD) fell 20.8% to settle at $2.36 amid continued profit takin.
  • Allbirds, Inc. (NASDAQ: BIRD) fell 19.2% to close at $4.58 after the company issued Q3 and FY22 sales guidance below estimates.
  • Clover Health Investments, Corp. (NASDAQ: CLOV) fell 17.9% to close at $2.79 after the company reported financial results and reaffirmed full-year guidance.
  • Standard BioTools Inc. (NYSE: LAB) declined 17.7% to settle at $1.68 following Q2 results.
  • Wayfair Inc. (NYSE: W) dropped 17% to close at $59.61.
  • Shift Technologies, Inc. (NASDAQ: SFT) fell 16.3% to close at $1.28.
  • The Beauty Health Company (NASDAQ: SKIN) dipped 16.2% to settle at $12.80 after the company reported Q2 earnings results.
  • Freshpet, Inc. (NASDAQ: FRPT) fell 15.1% to close at $47.84 after the company reported worse-than-expected Q2 EPS and sales results.
  • 3D Systems Corporation (NYSE: DDD) shares fell 15% to settle at $11.26 after the company reported a loss for its second quarter and lowered its FY22 sales guidance.
  • Trex Company, Inc. (NYSE: TREX) fell 15% to close at $54.28 following Q2 results.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 14.2% to close at $9.79. Baird downgraded Bed Bath & Beyond from Neutral to Underperform and announced a $4 price target.
  • Twist Bioscience Corporation (NASDAQ: TWST) dropped 14.2% to settle at $48.53. Twist Bioscience recently reported better-than-expected Q3 EPS and sales results and raised FY22 revenue guidance above analyst estimates.
  • Aterian, Inc. (NASDAQ: ATER) fell 14.1% to close at $2.56 as the company reported second-quarter financial results.
  • AdaptHealth Corp. (NASDAQ: AHCO) dipped 13.5% to settle at $22.24 after the company reported worse-than-expected Q2 EPS results.
  • bluebird bio, Inc. (NASDAQ: BLUE) fell 13.3% to close at $5.50 after jumping 13% on Monday.
  • Helios Technologies, Inc. (NASDAQ: HLIO) fell 13% to close at $61.15 after the company reported Q2 earnings results.
  • Onto Innovation Inc. (NYSE: ONTO) declined 12.1% to close at $74.81 after Q2 results.
  • Upstart (NASDAQ:UPST) Holdings, Inc (NASDAQ: UPST) fell 11.8% to close at $28.45 after the company reported Q2 results and issued Q3 sales guidance below estimates.
  • Signet Jewelers Limited (NYSE: SIG (LON:SHI)) declined 11.7% to close at $59.75 after the company cut FY23 sales guidance below analyst estimates.
  • ICU Medical, Inc. (NASDAQ: ICUI) fell 11.6% to close at $166.31 after the company reported worse-than-expected Q2 EPS and sales results.
  • Synaptics Incorporated (NASDAQ: SYNA) dropped 11.3% to close at $128.78.
  • ironSource Ltd. (NYSE: IS) fell 11.2% to settle at $4.20.
  • Nikola Corporation (NASDAQ: NKLA) dropped 10.6% to close at $6.96 amid profit taking in clean energy vehicles stocks as well as broader risk-off sentiment.
  • Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) fell 10.6% to close at $87.68.
  • Helbiz, Inc. (NASDAQ: HLBZ) fell 10.6% to close at $1.44 after jumping 115% on Monday.
  • Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) dipped 10.5% to close at $12.10 after the company reported worse-than-expected Q2 results and issued Q3 guidance below estimates.
  • Doximity, Inc. (NYSE: DOCS) fell 10.2% to settle at $36.49. Doximity recently lowered FY23 sales guidance.
  • Guardant Health, Inc. (NASDAQ: GH) dipped 10.2% to close at $48.96.
  • American Eagle Outfitters , Inc. (NYSE: NYSE:AEO) fell 9% to close at $11.49.
  • BIMI International Medical Inc. (NASDAQ: BIMI) shares fell 8.7% to close at $0.56. Fnu Oudom reported a stake of 44% in the company in a 13D filing.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) fell 6.9% to close at $0.1210. T2 Biosystems said it will explore potential to develop rapid molecular diagnostic test for monkeypox virus.
  • 23andMe Holding Co (NASDAQ: ME) fell 6.3% to close at $3.73 after the company reported worse-than-expected Q2 EPS results.
  • TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) fell 5.4% to close at $1.22. TOMI Environmental Solutions shares jumped over 29% on Monday after the company highlighted its SteraMist as a disinfectant against the Monkeypox virus.
  • Ralph Lauren Corporation (NYSE: NYSE:RL) fell 4.3% to close at $96.77 following Q1 results.
  • Tesla, Inc. (NASDAQ: TSLA) fell 2.4% to close at $850.00.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
 

Related Articles

Fresh strikes set to paralyse British rail network
Fresh strikes set to paralyse British rail network By Reuters - Oct 01, 2022

LONDON (Reuters) - Britain faces its largest rail strike in decades on Saturday as tens of thousands of workers across three trade unions walk out in disputes over pay and job...

S&P cuts UK rating outlook after tax cut plan
S&P cuts UK rating outlook after tax cut plan By Reuters - Sep 30, 2022 2

By David Milliken LONDON (Reuters) -Ratings agency Standard & Poor's cut the outlook for its AA credit rating for British sovereign debt on Friday to "negative" from "stable" as...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email